Related Experiment Video
Updated: Feb 17, 2026

10:15
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
Published on: November 10, 2021
2.2K
Bone marrow-derived cPLA2α contributes to renal fibrosis progression
John R Montford1,2, Allison M B Lehman3, Colin D Bauer3
1Department of Medicine, Renal Division, University of Colorado Anschutz Medical Campus, Aurora, CO John.Montford@UCDenver.edu.
Journal of Lipid Research
|December 13, 2017
Summary
Group IVA calcium-dependent cytosolic phospholipase A2 (cPLA2α) in bone marrow cells significantly reduces renal fibrosis and inflammation following kidney injury. This highlights cPLA2α
Area of Science:
- Biochemistry
- Immunology
- Nephrology
Background:
- Group IVA calcium-dependent cytosolic phospholipase A2 (cPLA2α) mediates the
- Purpose_of_the_Study
- Main_Methods
- Main_Results
- Conclusions
- Meta_Description
- The role of cPLA2α in bone marrow-derived cells in renal fibrosis was investigated using a unilateral ureteral obstruction (UUO) mouse model. Bone marrow from wild-type (WT) or cPLA2α-deficient (KO) mice was transplanted into irradiated WT recipients. Following UUO, renal fibrosis, eicosanoid production, macrophage infiltration, and cytokine expression were assessed.
- Renal fibrosis was significantly attenuated in KO-bone marrow transplant (BMT) recipients compared to WT-BMT recipients. KO-BMT mice exhibited lower levels of pro-inflammatory eicosanoids, reduced infiltration of inflammatory macrophages, and decreased pro-inflammatory cytokine expression post-UUO.
- Bone marrow-derived cPLA2α plays a critical role in mediating kidney inflammation and fibrosis after injury through eicosanoid production. Targeting cPLA2α in these cells may offer a therapeutic strategy for renal fibrosis.
- Investigating cPLA2α's role in bone marrow cells reveals its impact on renal fibrosis and inflammation after injury.
Purpose of the Study:
- To determine the role of group IVA calcium-dependent cytosolic phospholipase A2 (cPLA2α) in bone marrow-derived cells in the pathogenesis of renal fibrosis.
- To elucidate the contribution of cPLA2α-mediated eicosanoid production in bone marrow cells to kidney injury and fibrosis following unilateral ureteral obstruction (UUO).
Main Methods:
- Utilized a murine model of renal fibrosis (UUO) involving bone marrow transplantation (BMT) from wild-type (WT) or cPLA2α-deficient (KO) donors into irradiated WT recipients.
- Assessed renal fibrosis using histological staining (picrosirius red, collagen-3, α-smooth muscle actin) at 3, 7, and 14 days post-UUO.
- Quantified eicosanoid levels via lipidomic analysis, evaluated macrophage infiltration (CD45+CD11b+Ly6Chi), and measured pro-inflammatory cytokine gene expression.
Main Results:
- Renal fibrosis was significantly attenuated in KO-BMT mice compared to WT-BMT mice after UUO.
- Lipidomic analysis revealed lower levels of pro-inflammatory eicosanoids in KO-BMT mice post-injury.
- KO-BMT mice showed reduced infiltration of pro-inflammatory macrophages and lower expression of pro-inflammatory cytokines.
Conclusions:
- Bone marrow-derived cPLA2α is a key mediator of eicosanoid production following renal injury.
- cPLA2α activity in bone marrow cells significantly contributes to renal fibrosis and inflammation.
- Targeting cPLA2α in bone marrow-derived cells presents a potential therapeutic avenue for mitigating renal fibrosis.
Keywords:
cytosolic calcium-dependent group IVA phospholipase A2αeicosanoidsextracellular matrixinflammationkidneylipidomicsphospholipases/A2
